nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Phase II Study to Determine the Safety and Efficacy of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase (IDO) Enzyme INCB024360 in Patients with Myelodysplastic Syndromes
|
Komrokji, Rami S. |
|
2019 |
19 |
3 |
p. 157-161 |
artikel |
2 |
Autologous Stem-Cell Transplantation for Primary Central Nervous System Lymphoma: Systematic Review and Meta-analysis
|
Alnahhas, Iyad |
|
2019 |
19 |
3 |
p. e129-e141 |
artikel |
3 |
Cardiovascular Risk and Cardiovascular Events in Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors
|
Assunção, Paola Morelato |
|
2019 |
19 |
3 |
p. 162-166 |
artikel |
4 |
Chronic Neutrophilic Leukemia: Current and Future Perspectives
|
Venugopal, Sangeetha |
|
2019 |
19 |
3 |
p. 129-134 |
artikel |
5 |
Clinicopathological Profile of Myelomatous Pleural Effusion: Single-center Real-world Experience and Review of Literature
|
Yanamandra, Uday |
|
2019 |
19 |
3 |
p. 183-189.e1 |
artikel |
6 |
Editorial Board
|
|
|
2019 |
19 |
3 |
p. A4-A5 |
artikel |
7 |
Efficacy and Feasibility of Allogeneic Hematopoietic Stem-Cell Transplantation in the Treatment of Refractory Acute Myeloid Leukemia
|
Ciftciler, Rafiye |
|
2019 |
19 |
3 |
p. 177-182 |
artikel |
8 |
Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin Lymphoma
|
Bond, David A. |
|
2019 |
19 |
3 |
p. e123-e128 |
artikel |
9 |
Incidence and Risk Factors for Developing Herpes Zoster Among a Cohort of Patients Diagnosed With Lymphoma at a Community Cancer Center
|
Goenaga Vázquez, Yamila |
|
2019 |
19 |
3 |
p. e153-e158 |
artikel |
10 |
Multicenter Phase 2 Study of Reduced-Dose CHOP Chemotherapy Combined With Rituximab for Elderly Patients With Diffuse Large B-Cell Lymphoma
|
Park, Sungwoo |
|
2019 |
19 |
3 |
p. 149-156 |
artikel |
11 |
Optimal Management of Adverse Events From Copanlisib in the Treatment of Patients With Non-Hodgkin Lymphomas
|
Cheson, Bruce D. |
|
2019 |
19 |
3 |
p. 135-141 |
artikel |
12 |
Outcome of Childhood Acute Megakaryoblastic Leukemia: Children’s Cancer Hospital Egypt 57357 Experience
|
Maarouf, Noura |
|
2019 |
19 |
3 |
p. e142-e152 |
artikel |
13 |
Phase II Trial of MEK Inhibitor Binimetinib (MEK162) in RAS-mutant Acute Myeloid Leukemia
|
Maiti, Abhishek |
|
2019 |
19 |
3 |
p. 142-148.e1 |
artikel |
14 |
Prognostic Value of 1q21 Gain in Multiple Myeloma
|
Chen, Dangui |
|
2019 |
19 |
3 |
p. e159-e164 |
artikel |
15 |
Progressive Elevation of NT-ProBNP During Chemotherapy Is Related to Asymptomatic Cardiovascular Events in Patients With Multiple Myeloma
|
Wang, Yutong |
|
2019 |
19 |
3 |
p. 167-176.e1 |
artikel |
16 |
Table of Contents
|
|
|
2019 |
19 |
3 |
p. A6-A8 |
artikel |